[ad_1]
Target’s stock rocketed Wednesday, after the discount retailer reported a triple beat for its fiscal second-quarter and raised its full-year profit outlook, citing “meaningfully” improving trends across discretionary categories.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...